Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-06-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/4990 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846144319238438912 |
|---|---|
| author | NICOLA SGHERZA Stefania Zucano Angelantonio Vitucci Antonio Palma Francesco Tarantini Daniela Campanale Luigi Vimercati Angela Maria Vittoria Larocca Domenico Visceglie Amalia Acquafredda Angelo Ostuni Daniela Di Gennaro Carmen Vitucci Silvio Tafuri Pellegrino Musto |
| author_facet | NICOLA SGHERZA Stefania Zucano Angelantonio Vitucci Antonio Palma Francesco Tarantini Daniela Campanale Luigi Vimercati Angela Maria Vittoria Larocca Domenico Visceglie Amalia Acquafredda Angelo Ostuni Daniela Di Gennaro Carmen Vitucci Silvio Tafuri Pellegrino Musto |
| author_sort | NICOLA SGHERZA |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d24fa06fb0994911b30c7936a8fccfbf |
| institution | Kabale University |
| issn | 2035-3006 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-d24fa06fb0994911b30c7936a8fccfbf2024-12-02T07:50:38ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062022-06-0114110.4084/MJHID.2022.056Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patientsNICOLA SGHERZA0Stefania ZucanoAngelantonio VitucciAntonio PalmaFrancesco TarantiniDaniela CampanaleLuigi VimercatiAngela Maria Vittoria LaroccaDomenico VisceglieAmalia AcquafreddaAngelo OstuniDaniela Di GennaroCarmen VitucciSilvio TafuriPellegrino Mustoa:1:{s:5:"en_US";s:85:"Unit of Hematology and Stem Cell Transplantation, AOU Consorziale Policlinico di Bari";}https://www.mjhid.org/index.php/mjhid/article/view/4990 |
| spellingShingle | NICOLA SGHERZA Stefania Zucano Angelantonio Vitucci Antonio Palma Francesco Tarantini Daniela Campanale Luigi Vimercati Angela Maria Vittoria Larocca Domenico Visceglie Amalia Acquafredda Angelo Ostuni Daniela Di Gennaro Carmen Vitucci Silvio Tafuri Pellegrino Musto Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients Mediterranean Journal of Hematology and Infectious Diseases |
| title | Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients |
| title_full | Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients |
| title_fullStr | Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients |
| title_full_unstemmed | Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients |
| title_short | Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients |
| title_sort | prospective case control study of serological response after two doses of bnt162b2 anti sars cov 2 mrna vaccine in transfusion dependent thalassemic patients |
| url | https://www.mjhid.org/index.php/mjhid/article/view/4990 |
| work_keys_str_mv | AT nicolasgherza prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT stefaniazucano prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT angelantoniovitucci prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT antoniopalma prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT francescotarantini prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT danielacampanale prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT luigivimercati prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT angelamariavittorialarocca prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT domenicovisceglie prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT amaliaacquafredda prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT angeloostuni prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT danieladigennaro prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT carmenvitucci prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT silviotafuri prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients AT pellegrinomusto prospectivecasecontrolstudyofserologicalresponseaftertwodosesofbnt162b2antisarscov2mrnavaccineintransfusiondependentthalassemicpatients |